Correlation Between Soleno Therapeutics and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Soleno Therapeutics and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Soleno Therapeutics and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Soleno Therapeutics and Aquestive Therapeutics, you can compare the effects of market volatilities on Soleno Therapeutics and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Soleno Therapeutics with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Soleno Therapeutics and Aquestive Therapeutics.
Diversification Opportunities for Soleno Therapeutics and Aquestive Therapeutics
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Soleno and Aquestive is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Soleno Therapeutics and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Soleno Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Soleno Therapeutics are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Soleno Therapeutics i.e., Soleno Therapeutics and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Soleno Therapeutics and Aquestive Therapeutics
Given the investment horizon of 90 days Soleno Therapeutics is expected to generate 0.58 times more return on investment than Aquestive Therapeutics. However, Soleno Therapeutics is 1.72 times less risky than Aquestive Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 5,531 in Soleno Therapeutics on August 29, 2024 and sell it today you would earn a total of 303.00 from holding Soleno Therapeutics or generate 5.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Soleno Therapeutics vs. Aquestive Therapeutics
Performance |
| Timeline |
| Soleno Therapeutics |
| Aquestive Therapeutics |
Soleno Therapeutics and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Soleno Therapeutics and Aquestive Therapeutics
The main advantage of trading using opposite Soleno Therapeutics and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Soleno Therapeutics position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| Soleno Therapeutics vs. Eliem Therapeutics | Soleno Therapeutics vs. Scpharmaceuticals | Soleno Therapeutics vs. Milestone Pharmaceuticals | Soleno Therapeutics vs. Seres Therapeutics |
| Aquestive Therapeutics vs. Capricor Therapeutics | Aquestive Therapeutics vs. Soleno Therapeutics | Aquestive Therapeutics vs. Bio Path Holdings | Aquestive Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |